Predictive value of symptoms for ovarian cancer: Comparison of symptoms reported by questionnaire, interview, and general practitioner notes

Journal of the National Cancer Institute

Volumn 104, Issue 2, 2012, Pages 114-124

  Lim, Anita W W ^a   Mesher, David ^a   Gentry Maharaj, Aleksandra ^b   Balogun, Nyaladzi ^b   Jacobs, Ian ^c   Menon, Usha ^b   Sasieni, Peter ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CANCER SCREENING; CONTROLLED STUDY; FEMALE; GENERAL PRACTICE; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; PREDICTIVE VALUE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUESTIONNAIRE; REVIEW; SENSITIVITY AND SPECIFICITY; SYMPTOMATOLOGY; TELECONSULTATION;

ABDOMINAL PAIN; AGED; ANOREXIA; CARCINOMA; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; CONFOUNDING FACTORS (EPIDEMIOLOGY); CONSTIPATION; DIARRHEA; DYSPEPSIA; EARLY DETECTION OF CANCER; FATIGUE; FEMALE; GENERAL PRACTITIONERS; HUMANS; INTERVIEWS AS TOPIC; LOGISTIC MODELS; LOW BACK PAIN; MASS SCREENING; MEDICAL RECORDS; MIDDLE AGED; NAUSEA; NEOPLASM STAGING; ODDS RATIO; OVARIAN NEOPLASMS; PREDICTIVE VALUE OF TESTS; QUESTIONNAIRES; REGRESSION ANALYSIS; SELF REPORT; SENSITIVITY AND SPECIFICITY; TELEPHONE; TIME FACTORS; URINARY INCONTINENCE, URGE; UTERINE HEMORRHAGE; VOMITING; WEIGHT LOSS;

EID: 84856197554     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djr486     Document Type: Review

References (36)

1. Andersen MR, Goff BA, Lowe KA, et al. Use of a symptom index, CA125, and HE4 to predict ovarian cancer. Gynecol Oncol. 2009;116(3):378-383.
2. Andersen MR, Goff BA, Lowe KA, et al. Combining a symptoms index with CA 125 to improve detection of ovarian cancer. Cancer. 2008;113(3):484-489.
3. Goff BA, Mandel LS, Drescher CW, et al. Development of an ovarian cancer symptom index: possibilities for earlier detection. Cancer. 2007;109(2):221-227. (Pubitemid 46106236)
4. Kim MK, Kim K, Kim SM, et al. A hospital-based case-control study of identifying ovarian cancer using symptom index. J Gynecol Oncol. 2009;20(4):238-242.
5. Lurie G, Thompson PJ, McDuffie KE, Carney ME, Goodman MT. Prediagnostic symptoms of ovarian carcinoma: a case-control study. Gynecol Oncol. 2009;114(2):231-236.
6. Rossing MA, Wicklund KG, Cushing-Haugen KL, Weiss NS. Predictive value of symptoms for early detection of ovarian cancer. J Natl Cancer Inst. 2010;102(4):222-229.
7. Jordan SJ, Coory MD, Webb PM. Re: predictive value of symptoms for early detection of ovarian cancer. J Natl Cancer Inst. 2010;102(20):1599-1601.
8. Gynecologic Cancer Foundation SoGO, American Cancer Society. Ovarian Cancer Symptoms Consensus Statement. http://www.wcn.org/ov-cancer-cons.html. Accessed May 11, 2011.
9. Eve Appeal, Ovacome. Ovarian Cancer UK Consensus Statement. http://www.eveappeal.org.uk/media/5381/ ovarian%20cancer%20uk%20consensus%20statement.pdf. Accessed February 1, 2011.
10. Department of Health. Ovarian Cancer: Key Messages for Health Professionals. http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/ PublicationsPolicyAndGuidance/DH-110534. Accessed February 4, 2011.
11. Kroenke K. Studying symptoms: sampling and measurement issues. Ann Intern Med. 2001;134(9, pt 2):844-853. (Pubitemid 32405692)
12. Balogun N, Gentry-Maharaj A, Wozniak EL, et al. Recruitment of newly diagnosed ovarian cancer patients proved challenging in a multicentre biobanking study. J Clin Epidemiol. 2010;64(5):525-530.
13. Menon U, Gentry-Maharaj A, Hallett R, et al. Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). Lancet Oncol. 2009;10(4):327-340.
14. Attanucci CA, Ball HG, Zweizig SL, Chen AH. Differences in symptoms between patients with benign and malignant ovarian neoplasms. Am J Obstet Gynecol. 2004;190(5):1435-1437. (Pubitemid 38692240)
15. Chan YM, Ng TY, Lee PW, Ngan HY, Wong LC. Symptoms, coping strategies, and timing of presentations in patients with newly diagnosed ovarian cancer. Gynecol Oncol. 2003;90(3):651-656.
16. Eltabbakh GH, Yadav PR, Morgan A. Clinical picture of women with early stage ovarian cancer. Gynecol Oncol. 1999;75(3):476-479.
17. Flam F, Einhorn N, Sjovall K. Symptomatology of ovarian cancer. Eur J Obstet Gynecol Reprod Biol. 1988;27(1):53-57.
18. Goff BA, Mandel L, Muntz HG, Melancon CH. Ovarian carcinoma diagnosis. Cancer. 2000;89(10):2068-2075.
19. Goff BA, Mandel LS, Melancon CH, Muntz HG. Frequency of symptoms of ovarian cancer in women presenting to primary care clinics. JAMA. 2004;291(22):2705-2712. (Pubitemid 38725419)
20. Kirwan JM, Tincello DG, Herod JJ, Frost O, Kingston RE. Effect of delays in primary care referral on survival of women with epithelial ovarian cancer: retrospective audit. BMJ. 2002;324(7330):148-151. (Pubitemid 34084507)
21. Olson SH, Mignone L, Nakraseive C, et al. Symptoms of ovarian cancer. Obstet Gynecol. 2001;98(2):212-217. (Pubitemid 32744751)
22. Smith EM, Anderson B. The effects of symptoms and delay in seeking diagnosis on stage of disease at diagnosis among women with cancers of the ovary. Cancer. 1985;56(11):2727-2732. (Pubitemid 16249944)
23. Vine MF, Calingaert B, Berchuck A, Schildkraut JM. Characterization of prediagnostic symptoms among primary epithelial ovarian cancer cases and controls. Gynecol Oncol. 2003;90(1):75-82. (Pubitemid 37338079)
24. Vine MF, Ness RB, Calingaert B, Schildkraut JM, Berchuck A. Types and duration of symptoms prior to diagnosis of invasive or borderline ovarian tumor. Gynecol Oncol. 2001;83(3):466-471. (Pubitemid 33139704)
25. Webb PM, Purdie DM, Grover S, et al. Symptoms and diagnosis of borderline, early and advanced epithelial ovarian cancer. Gynecol Oncol. 2004;92(1):232-239. (Pubitemid 38147397)
26. Wikborn C, Pettersson F, Silfversward C, Moberg PJ. Symptoms and diagnostic difficulties in ovarian epithelial cancer. Int J Gynaecol Obstet. 1993;42(3):261-264. (Pubitemid 23278841)
27. Yawn BP, Barrette BA, Wollan PC. Ovarian cancer: the neglected diagnosis. Mayo Clin Proc. 2004;79(10):1277-1282. (Pubitemid 39299073)
28. Andersen RS, Vedsted P, Olesen F, Bro F, Sondergaard J. Patient delay in cancer studies: a discussion of methods and measures. BMC Health Serv Res. 2009;9(189). doi:10.1186/1472-6963-9-189.
29. Bankhead CR, Collins C, Stokes-Lampard H, et al. Identifying symptoms of ovarian cancer: a qualitative and quantitative study. BJOG. 2008;115(8):1008- 1014. (Pubitemid 351841782)
30. Funch DP. Predictors and consequences of symptom reporting behaviors in colorectal cancer patients. Med Care. 1988;26(10):1000-1008.
31. Wallander MA, Dimenas E, Svardsudd K, Wiklund I. Evaluation of three methods of symptom reporting in a clinical trial of felodipine. Eur J Clin Pharmacol. 1991;41(3):187-196.
32. Hamilton W, Peters TJ, Bankhead C, Sharp D. Risk of ovarian cancer in women with symptoms in primary care: population based case-control study. BMJ. 2009;339:b2998. doi:10.1136/bmj.b2998.
33. Rufford BD, Jacobs I, Menon U. Feasibility of screening for ovarian cancer using symptoms as selection criteria. BJOG. 2007;114(1):59-64. (Pubitemid 44923933)
34. Friedman GD, Skilling JS, Udaltsova NV, Smith LH. Early symptoms of ovarian cancer: a case-control study without recall bias. Fam Pract. 2005;22(5):548-553. (Pubitemid 41418776)
35. Smith LH, Morris CR, Yasmeen S, et al. Ovarian cancer: can we make the clinical diagnosis earlier? Cancer. 2005;104(7):1398-1407.
36. Wynn ML, Chang S, Peipins LA. Temporal patterns of conditions and symptoms potentially associated with ovarian cancer. J Womens Health (Larchmt). 2007;16(7):971-986. (Pubitemid 47479941)